High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia.
暂无分享,去创建一个
Ji Eun Lee | H. Yoo | C. Shin | Dae-Yeol Lee | Jung Hyun Lee | Gu-Hwan Kim | B. Lee | Jin-Ho Choi | H. Chung | W. Cho | Byung-Kyu Suh | H. Kim | C. Kim | J. Shin | Jeesuk Yu | Jae‐Min Kim
[1] H. Yoo,et al. Ovarian cyst torsion in a patient with congenital lipoid adrenal hyperplasia , 2011, European Journal of Pediatrics.
[2] J. Lehoux,et al. Gonadal function, first cases of pregnancy, and child delivery in a woman with lipoid congenital adrenal hyperplasia. , 2009, The Journal of clinical endocrinology and metabolism.
[3] W. Miller,et al. Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc. , 2008, The Journal of clinical endocrinology and metabolism.
[4] W. Chung,et al. Role of a founder c.201_202delCT mutation and new phenotypic features of congenital lipoid adrenal hyperplasia in Palestinians. , 2007, The Journal of clinical endocrinology and metabolism.
[5] G. Theintz,et al. A novel mutation L260P of the steroidogenic acute regulatory protein gene in three unrelated patients of Swiss ancestry with congenital lipoid adrenal hyperplasia. , 2005, The Journal of clinical endocrinology and metabolism.
[6] Xin Chen,et al. A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings. , 2005, The Journal of clinical endocrinology and metabolism.
[7] J. Breslow,et al. StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism* , 2003, Journal of Biological Chemistry.
[8] Toshiaki Tanaka,et al. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. , 2002, The Journal of clinical endocrinology and metabolism.
[9] J. Nakae,et al. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. , 2001, The Journal of clinical endocrinology and metabolism.
[10] W. Miller,et al. Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. , 2000, The Journal of clinical endocrinology and metabolism.
[11] R. Horikawa,et al. A novel compound heterozygous mutation in the steroidogenic acute regulatory protein gene in a patient with congenital lipoid adrenal hyperplasia. , 1999, The Journal of clinical endocrinology and metabolism.
[12] W. Miller,et al. Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StARProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[13] A. Weiss,et al. Effect of truncated forms of the steroidogenic acute regulatory protein on intramitochondrial cholesterol transfer. , 1998, Endocrinology.
[14] H. Watari,et al. The Mechanism of Action of Steroidogenic Acute Regulatory Protein (StAR) , 1998, The Journal of Biological Chemistry.
[15] H. Yoo,et al. Molecular and Clinical Characterization of Korean Patients with Congenital Lipoid Adrenal Hyperplasia , 1998, Journal of pediatric endocrinology & metabolism : JPEM.
[16] W. Miller. Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. , 1997, Journal of molecular endocrinology.
[17] W. Miller,et al. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. , 1997, The Journal of clinical endocrinology and metabolism.
[18] K. Tachibana,et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. , 1997, Human molecular genetics.
[19] K. Tachibana,et al. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. , 1997, The Journal of clinical investigation.
[20] Toshiaki Tanaka,et al. Detection of the Missense Mutation A218V in the Steroidogenic Acute Regulatory Protein Gene of a Japanese Patient with Congenital Lipoid Adrenal Hyperplasia , 1997 .
[21] W. Miller,et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. , 1996, The New England journal of medicine.
[22] D. Pain,et al. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] W. Miller,et al. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. , 1995, Biochemistry.
[24] A. Rogol,et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.
[25] S. Black,et al. Construction and function of fusion enzymes of the human cytochrome P450scc system. , 1993, DNA and cell biology.